Elevance Health Inc. (ELV) Tops Q1 EPS by $1.74, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ELV Hot Sheet
Join SI Premium – FREE
Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $12.58, $1.74 better than the analyst estimate of $10.84. Revenue for the quarter came in at $49.5 billion versus the consensus estimate of $48.2 billion.
GUIDANCE:
Elevance Health Inc. sees FY2026 EPS of $26.75, versus the consensus of $25.75.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Credit Acceptance ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
- Bernstein SocGen on Neurocrine Bio. (NBIX): 'This latest Crenessity beat may serve as the positive inflection point'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
